Intraosseous Access Procedure in Elderly Patients
Intraosseous (IO) access should be obtained early when peripheral IV access is difficult or delayed in elderly patients, using either the proximal tibia (0.5 cm below tibial tuberosity on medial midline) or proximal humerus, with a power drill device and 13-15 gauge needle inserted perpendicular to the bone until loss of resistance is felt. 1, 2
Site Selection
The two primary anatomical sites for IO access in elderly patients are:
- Proximal tibia: Insert at 0.5 cm below the tibial tuberosity in the midline of the medial surface, where cortex is thinnest and medullary cavity is widest 3
- Proximal humerus: Alternative site, though optimal anatomical location between tibial versus humeral remains a knowledge gap 1
The distal tibia (above medial malleolus) has been successfully used in adults aged 36-84 years during cardiac arrest, though this is less commonly recommended 4.
Equipment Required
- Power drill IO device (most widespread and preferred) 5
- 13-15 gauge IO needle (standard length should be 17 mm excluding skin thickness) 3, 4
- Standard IV tubing
- Pressure bag capable of delivering 300 mmHg 4
- Lidocaine for IO analgesia in awake patients 2
Step-by-Step Procedure
Identify landmarks: Palpate tibial tuberosity and mark insertion point 0.5 cm distal on medial midline 3
Prepare site: Clean with antiseptic solution
Analgesia for awake patients: Consider IO lidocaine administration before initial flush to improve tolerance 2
Insert needle: Hold drill perpendicular to bone surface, apply firm downward pressure while activating drill until sudden loss of resistance indicates entry into medullary cavity 5
Confirm placement using multimodal approach 2:
- Needle stands upright without support
- Aspiration of bone marrow (may not always be possible)
- Flush flows without resistance or extravasation
- No subcutaneous swelling
Secure and connect: Attach to IV tubing with pressure bag set to 300 mmHg for adequate flow rates (5-12 mL/min) 4
Critical Timing Considerations
IO access should be considered early in high-acuity situations rather than after multiple failed IV attempts. The 2025 AHA guidelines note that while peripheral IV remains traditionally preferred, IO access is an acceptable alternative when IV access is not readily available, with placement achievable in under one minute 1, 4. The procedure has a short learning curve and high success rates 5.
Monitoring and Complications
Vigilant monitoring is essential for:
- Extravasation (most common complication)
- Neurovascular compromise 2
- Compartment syndrome
Major complications are very rare when proper technique is used 2, 5.
Drug Administration
All standard resuscitation medications can be administered via IO route, including epinephrine, atropine, sodium bicarbonate, lidocaine, and vasopressors, with temporally related pharmacologic effects observed 1, 4. However, the 2025 AHA guidelines note lower odds of achieving sustained ROSC with IO versus IV route (OR 0.89; 95% CI, 0.80-0.99), though no differences in survival to discharge or neurological outcomes were found 1.
Laboratory Considerations
IO-derived laboratory results can be useful when no alternative access exists but should be treated as provisional and confirmed once definitive vascular access is secured 2.
Special Considerations for Elderly Patients
The procedure has been successfully demonstrated in adults aged 36-84 years (mean 65.1 years) during cardiac arrest, showing that age itself is not a contraindication 4. The technique is particularly valuable in elderly patients who often have difficult venous access due to fragile veins, edema, or chronic illness.